Vonjo
Drug
CTI BioPharma Corp.
Total Payments
$4.2M
Transactions
6,114
Doctors
3,067
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $136.76 | 1 | 1 |
| 2023 | $3.1M | 4,188 | 2,430 |
| 2022 | $1.0M | 1,925 | 1,285 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.3M | 128 | 55.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $630,943 | 289 | 15.1% |
| Honoraria | $470,643 | 266 | 11.3% |
| Consulting Fee | $231,503 | 69 | 5.5% |
| Grant | $153,435 | 2 | 3.7% |
| Food and Beverage | $146,504 | 5,072 | 3.5% |
| Space rental or facility fees (teaching hospital only) | $127,780 | 36 | 3.1% |
| Travel and Lodging | $110,127 | 246 | 2.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,000 | 6 | 0.2% |
Payments by Type
Research
$2.3M
128 transactions
General
$1.9M
5,986 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Phase 1, Open Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pacritinib in Subjects with Varying Degrees Hepatic Impairment Compared to Healthy Subjects | CTI BioPharma Corp. | $1.6M | 0 |
| PACIFICA Phase 3 | CTI BioPharma Corp. | $677,285 | 0 |
Top Doctors Receiving Payments for Vonjo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Tampa, FL | $2.6M | 166 |
| , M.D | Hematology | Hackensack, NJ | $88,202 | 65 |
| , N.P | Acute Care | Los Angeles, CA | $87,039 | 66 |
| , M.D | Hematology | Hackensack, NJ | $84,111 | 72 |
| , PA-C | Physician Assistant | Fort Worth, TX | $57,769 | 67 |
| , M.D | Internal Medicine | Loma Linda, CA | $50,630 | 34 |
| , PA-C | Physician Assistant | Phoenix, AZ | $48,091 | 60 |
| , NP | Nurse Practitioner | Indianapolis, IN | $47,582 | 54 |
| , MD | Hematology & Oncology | New York, NY | $40,397 | 18 |
| , MD | Medical Oncology | Glendale, AZ | $38,196 | 33 |
| , MD | Medical Oncology | New York, NY | $29,424 | 12 |
| Bart Scott | Medical Oncology | Seattle, WA | $28,678 | 29 |
| , M.D | Internal Medicine | Cleveland, OH | $28,329 | 23 |
| , ARNP | Nurse Practitioner | Tampa, FL | $27,508 | 25 |
| , MD | Hematology | Boston, MA | $26,053 | 14 |
| , MD | Medical Oncology | Dallas, TX | $25,754 | 25 |
| , M.D | Hematology | Tampa, FL | $24,482 | 21 |
| , D.O | Internal Medicine | Nampa, ID | $22,549 | 25 |
| , NP | Adult Health | New York, NY | $21,689 | 25 |
| , MD | Internal Medicine | Houston, TX | $18,793 | 10 |
| , MD | Hematology & Oncology | New Orleans, LA | $18,736 | 13 |
| , M.D., PHD | Medical Oncology | Houston, TX | $18,429 | 6 |
| , MD | Student in an Organized Health Care Education/Training Program | Kansas City, KS | $18,410 | 6 |
| , MD | Medical Oncology | Irvine, CA | $17,564 | 11 |
| , M.D | Hematology | Philadelphia, PA | $15,179 | 8 |
Ad
Manufacturing Companies
- CTI BioPharma Corp. $4.2M
- SOBI, INC $136.76
Product Information
- Type Drug
- Total Payments $4.2M
- Total Doctors 3,067
- Transactions 6,114
About Vonjo
Vonjo is a drug associated with $4.2M in payments to 3,067 healthcare providers, recorded across 6,114 transactions in the CMS Open Payments database. The primary manufacturer is CTI BioPharma Corp..
Payment data is available from 2022 to 2024. In 2024, $136.76 was paid across 1 transactions to 1 doctors.
The most common payment nature for Vonjo is "Unspecified" ($2.3M, 55.0% of total).
Vonjo is associated with 2 research studies, including "A Phase 1, Open Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pacritinib in Subjects with Varying Degrees Hepatic Impairment Compared to Healthy Subjects" ($1.6M).